Allovirinc Stock Current Asset
| ALVR Stock | USD 0.78 0.01 1.27% |
AllovirInc fundamentals help investors to digest information that contributes to AllovirInc's financial success or failures. It also enables traders to predict the movement of AllovirInc Stock. The fundamental analysis module provides a way to measure AllovirInc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AllovirInc stock.
At this time, AllovirInc's Other Current Assets are relatively stable compared to the past year. As of 04/25/2024, Total Current Assets is likely to grow to about 219.6 M, while Non Current Assets Total are likely to drop slightly above 3 M. AllovirInc | Current Asset |
AllovirInc Company Current Asset Analysis
AllovirInc's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current AllovirInc Current Asset | 61.62 M |
Most of AllovirInc's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AllovirInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
AllovirInc Current Asset Historical Pattern
Today, most investors in AllovirInc Stock are looking for potential investment opportunities by analyzing not only static indicators but also various AllovirInc's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of AllovirInc current asset as a starting point in their analysis.
AllovirInc Current Asset |
| Timeline |
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
AllovirInc Total Assets
Total Assets |
|
In accordance with the recently published financial statements, AllovirInc has a Current Asset of 61.62 M. This is 97.14% lower than that of the Biotechnology sector and 94.19% lower than that of the Health Care industry. The current asset for all United States stocks is 99.34% higher than that of the company.
AllovirInc Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AllovirInc's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AllovirInc could also be used in its relative valuation, which is a method of valuing AllovirInc by comparing valuation metrics of similar companies.AllovirInc is currently under evaluation in current asset category among related companies.
AllovirInc Current Valuation Drivers
We derive many important indicators used in calculating different scores of AllovirInc from analyzing AllovirInc's financial statements. These drivers represent accounts that assess AllovirInc's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of AllovirInc's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.7B | 1.0B | 812.4M | 393.2M | 70.7M | 67.2M | |
| Enterprise Value | 1.6B | 920.0M | 640.8M | 322.5M | 8.0M | 7.6M |
AllovirInc Fundamentals
| Return On Equity | -1.03 | ||||
| Return On Asset | -0.48 | ||||
| Current Valuation | (68.24 M) | ||||
| Shares Outstanding | 114.87 M | ||||
| Shares Owned By Insiders | 48.95 % | ||||
| Shares Owned By Institutions | 42.93 % | ||||
| Number Of Shares Shorted | 6.3 M | ||||
| Price To Book | 0.60 X | ||||
| Gross Profit | 165 K | ||||
| EBITDA | (180.93 M) | ||||
| Net Income | (190.42 M) | ||||
| Cash And Equivalents | 172.67 M | ||||
| Cash Per Share | 1.91 X | ||||
| Total Debt | 27.43 M | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 8.18 X | ||||
| Book Value Per Share | 1.31 X | ||||
| Cash Flow From Operations | (124.45 M) | ||||
| Short Ratio | 12.99 X | ||||
| Earnings Per Share | (1.83) X | ||||
| Price To Earnings To Growth | (0.06) X | ||||
| Target Price | 1.0 | ||||
| Number Of Employees | 112 | ||||
| Beta | 0.85 | ||||
| Market Capitalization | 90.85 M | ||||
| Total Asset | 190.8 M | ||||
| Retained Earnings | (656.19 M) | ||||
| Working Capital | 159.27 M | ||||
| Current Asset | 61.62 M | ||||
| Current Liabilities | 53.23 M | ||||
| Net Asset | 190.8 M |
About AllovirInc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AllovirInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AllovirInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AllovirInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with AllovirInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AllovirInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AllovirInc will appreciate offsetting losses from the drop in the long position's value.Moving together with AllovirInc Stock
| 0.73 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
| 0.8 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
Moving against AllovirInc Stock
| 0.52 | GILD | Gilead Sciences Earnings Call Today | PairCorr |
The ability to find closely correlated positions to AllovirInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AllovirInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AllovirInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AllovirInc to buy it.
The correlation of AllovirInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AllovirInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AllovirInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AllovirInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out AllovirInc Piotroski F Score and AllovirInc Altman Z Score analysis. To learn how to invest in AllovirInc Stock, please use our How to Invest in AllovirInc guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for AllovirInc Stock analysis
When running AllovirInc's price analysis, check to measure AllovirInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AllovirInc is operating at the current time. Most of AllovirInc's value examination focuses on studying past and present price action to predict the probability of AllovirInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AllovirInc's price. Additionally, you may evaluate how the addition of AllovirInc to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |
Is AllovirInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AllovirInc. If investors know AllovirInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AllovirInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.83) | Return On Assets (0.48) | Return On Equity (1.03) |
The market value of AllovirInc is measured differently than its book value, which is the value of AllovirInc that is recorded on the company's balance sheet. Investors also form their own opinion of AllovirInc's value that differs from its market value or its book value, called intrinsic value, which is AllovirInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AllovirInc's market value can be influenced by many factors that don't directly affect AllovirInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AllovirInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if AllovirInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AllovirInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.